You are here

P&T News

July 29

Drug aims to treat adults with nonalcoholic steatohepatitis with liver fibrosis
Oral treatment has the potential to induce and maintain remission
AptaTRACE helps to identify molecules that may be effective in targeted therapies
CARB-X seeks to accelerate antibiotic products research and development
System would use microbes for manufacturing small amounts of vaccines and other therapies

July 28

EHRs do not increase inpatient mortality, adverse safety events
The drug is approved as Lyxumia in more than 60 countries
WatchPAT approved for diagnostic testing on patients as young as 12 years old
Antibody adds to toolkits of biologics manufacturers, regulators

July 27

Respondents worry about gene editing and synthetic blood
Risks outweigh benefits in certain patients
Experts find little evidence to support routine screening in adults

July 26

Hospitals would receive quality-adjusted pricing for heart attack and bypass care
Growing percentage of patients combine drugs without physician’s knowledge
Product is extended-release formulation of Viekira Pak
Pregnant women are at risk of exposure from partners of either gender
Celgene won’t pursue indication for diffuse B-cell lymphoma

Pages